PRKCA and heart failure: Genetic abolition of Prkca or pharmacological inhibition of PKC-α/β results in either improved cardiac function or cardio-protection from heart failure in mice, rat and pig heart failure models, thereby implicating PKC-α in cardiac function and heart failure development and progression [30,31,39,40].